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SUMMARY 
Cassia tora L. (Family Leguminosae/Caesalpinioideae), is a plant with enormous medicinal 
values. The chloroform, methanol and aqueous extract of leaves of Cassia tora L. showed 
antibacterial activity (0-5000 μg/ml) against 38, 58 and 29 bacterial strains respectively 
out of 120 various bacterial strains and also methanol extracts showed antifungal activity 
(0-64mg/ml) against 3 strains out of 4 strains. Five strains of Shigella dysenteriae, four 
strains of Staphylococcus aureus, and three strains of Escherichia coli, have shown 
sensitivity against in vitro treatment of the methanol extracts up to 2000 μg/ml 
concentration. The minimum inhibitory concentration (MIC) values ranges from 2–64 
mg/ml for dermatophytes. Minimal Bactericidal Concentration (MBC) value lies in the 
range of 2000-2500 μg/ml against Escherichia coli ATCC25938 and Shigella dysenteriae 1. 
Phytochemical study indicates that the leaf extract contains flavonoids, saponins, resins, 
phytosterol, alkaloids and carbohydrates. The traditional claim of leaves of C. tora as an 
antimicrobial property have been confirmed as the extracts displayed activity against 
some bacteria and fungi which cause skin infection and gastro-intestinal disorder. 
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1. Introduction 
Many of the developing countries 
practice traditional medicine as its main 
source of healthcare, which is usually of 
plant origin (Ahmad et al., 2008; Stephen 
Bent, 2008). Today, nearly 88% of the global 
populations switch to plant derived 
medicines as their first line of defense for 
maintaining health and combating diseases 
(Kintzios et al., 2006). Pathogenic bacteria 
have developed resistance against existing 
antibiotics due to indiscriminate use of 
antimicrobial drugs to treat the infectious 
diseases (Qadrie et al., 2009; Pattnaik and 
Sharma, 2004)., as a result the treatment 
failure and health care cost have raised day 
by day. This has encouraged the 
microbiologists all over the world to 
formulate new antimicrobial agents and 
evaluation of the efficacy of natural plant 
products as the substitute for chemical 
antimicrobial agents (Alviano and Alviano, 
2009; Cowan, 1999). 
Bioactive compounds are normally 
accumulated as secondary metabolites in all 
plant cells but their concentration varies 
according to the plant parts, season, climate 
and particular growth phase. Leaf is one of 
the highest accumulator plant parts of such 
compounds and people are generally 
preferred it for therapeutic purposes. Some 
of the active compounds inhibit the growth 
of disease causing microbes either singly or 
in combination (Mukherjee and Wahile, 
2006). They can inhibit the growth of 
microbes by binding their surface proteins, 
breaking the peptide bonds, acting as 
chelating agents, altering their biochemical 
systematic or by preventing utilization of 
available nutrients to the microorganisms. 
Gouranga Das et al./J Phytol 2/5 (2010) 64-72 
 
Some compounds also cause lyses of 
microbial cells (Mukherjee and Wahile, 2006). 
Cassia tora L, family Leguminosae/ 
Caesalpinioideae is known as Charota (Hindi), 
chakunda (Bengali), and in English it is 
called Foetid cassia (Oudhia, 2002). 
Traditionally reported that Cassia tora L. have 
medicinal properties, like laxative, 
antiperiodic, antihelmintic, ophthalmic, and 
effective for leprosy, ringworm, flatulence, 
colic, dyspepsia, constipation, cough, 
bronchitis, cardiac disorders, etc (Nadkarni, 
1985; Chatterjee and Pakrashi, 1992)The 
leaves and seeds are useful in leprosy, 
ringworm, flatulence, colic, dyspepsia, 
constipation, cough, bronchitis, cardiac 
disorders (Oudhia, 2002). These herbs have 
been reported for their usefulness in the form 
of decoctions, infusions and tinctures in 
traditional system of medicines for treating 
skin diseases like psoriasis, leprosy etc. 
(Horvath, 1992; Zahra et al., 2000; Cordova et 
al., 2002; Harrison and Dorothy, 2003). Cassia 
tora L. have the hepatoprotective effects 
against carbon tetrachloride induced liver 
damage (Rajan et al., 2009). The root of Cassia 
tora L. exhibited substantial antishigellosis 
activity (Shahnaj et al., 2004). Cassia tora L. 
leaves have anthelmintic property for the 
presence of flavonoid (John et al., 2009). 
Aqueous extracts of seeds of Cassia tora L. 
exhibited better antibacterial activity 
(Staphylococcus aureus was more susceptible) 
as compared to petroleum ether, methanolic 
and ethanolic extracts (Roopashree et al. 
2008).  
Hence, the present investigation was 
carried out to evaluate the antibacterial 
activity of Cassia tora, leaves extract using 
different solvents and their aqueous extracts 
against several bacteria that can cause skin 
diseases and gastro-intestinal disorders in 
man. 
 
2. Materials and Method 
Extraction 
The leaves of Cassia tora L. was collected 
from the Jalpaiguri district, West Bengal, 
India during the month of May and June, 
2009. Extraction was carried out at room 
temperature under normal conditions. The 
leaves were shade dried for seven days and 
powdered and weighed 100 gm. Dried 
powdered leaves of Cassia tora L. were 
macerated in a 500 ml conical flask at room 
temperature using pet-ether, chloroform, 
methanol, and water successively for 72 hrs 
each, which was the modified method of 
CSIR protocol(CSIR Protocol, 1997). Before 
extraction with the next solvent the powder 
was air dried to remove the adhering solvent. 
The extracts were filtered and the solvent 
was evaporated to dryness under reduced 
pressure in an Eyela Rotary Evaporator at 
40–45°C. All the extracts were used for 
Phytochemical and antibacterial study. 
 
Phytochemical evaluation 
 Phytochemical examinations were carried 
out for all the extracts as per the standard 
methods (in Table 1) (Ellen and Sydney, 1990; 
Brain and Turner, 1975; Evans, 1996). 
Microorganisms 
The total of 120 strains of bacteria out of 
which 4 Gram positive and 8 Gram negative 
genera and 4 types of fungal strains were 
used in this study. All these bacterial strains 
and fungal strains are preserved in the 
Division of Microbiology, Dept. of 
Pharmaceutical Technology, Jadavpur 
University, Kolkata-32, West Bengal, India. 
The bacterial strains were grown in blood 
agar or MacConkey agar plates at 37 °C and 
maintained on nutrient agar (Hi-media) 
slants while the fungi were grown at 30 °C 
and maintained in Saboraud glucose agar 
slants. 
 
Preparation of inoculums: McFarland 
Nephelometer Standard (Roopashree et al., 
2008) method was followed for the 
preparation of suspension of organisms. A 24 
hour old culture was used for the 
preparation of bacterial suspension. 
Suspension of organism was made in a 
sterile isotonic solution of sodium chloride 
(0.9% w/v) and the turbidity was controlled 
in such a way that each ml of suspension 
contained approximately 1.5 x 108 cells/ml. It 
was obtained by adjusting the optical density 
of the bacterial suspension to that of a 
solution of 0.05ml of 1.175% of barium 
chloride and 9.95 ml of 1% sulphuric acid. 
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Table -1. Different biochemical tests with respect to different Phytochemicals 
 
Phytochemicals Name of test performed 
Alkaloids a) Mayer‟s Test 
b) Dragendorff‟s Test 
c) Wagner‟s Test 
d) Hager‟s test 
Carbohydrates a) Molisch‟s Test 
b) Benedict‟s Test 
c) Fehling‟s Test 
Glycosides a) Modified Borntrager‟s Test 
b) Legal‟s Test 
Saponins a) Froth Test 
b) Foam Test 
Phytosterols a) Salkowski‟s Test 
b) Libermann Burchard‟s Test 
Phenolic compounds a) Ferric Chloride Test 
Tannins a) Gelatin Test 
Flavonoids a) Alkaline Reagent Test 
b) Lead acetate Test 
c) Shinoda Test 
d) Zinc hydrochloric acid reduction Test 
 
Antimicrobial assay 
Sensitivity tests were performed by disk 
diffusion method, as per (NCCLS, 1993) 
protocol. The Mueller Hinton agar (Hi-media) 
plates, containing an inoculum size of 106 
cfu/ml of bacteria or 2×105 yeast cells or 
fungal spores on Saboraud glucose agar (Hi-
media) plates, were used. Previously 
prepared extract impregnated discs at 
concentrations of 0–5000 µg/ml for bacteria 
and 0–64 mg/ml for yeasts and fungi were 
placed aseptically on sensitivity plates with 
appropriate controls (Chattopadhyay et al., 
1998b). All the plates were then incubated at 
37 °C overnight for bacteria yeasts and at 
30 °C for 3 days in the case of fungi. The 
sensitivity was recorded by measuring the 
clear zone of growth inhibition on agar 
surface around the discs. 
 
Determination of minimum inhibitory 
concentration (MIC) 
MIC was determined both by agar and 
broth dilution methods (Chattopadhyay et 
al., 1998a). A 2-fold serial dilutions (0–5000 
µg/ml for bacteria and 0–64 mg/ml for fungi) 
of the extracts, with appropriate antibiotic 
control were prepared in Mueller Hinton 
broth for bacteria (Chattopadhyay et al., 
1998b) and Saboraud glucose broth for fungi 
(Ibrahim and Osman, 1995). For agar 
dilution assay previously prepared 
sensitivity plates, using serial 2-fold 
dilutions of the extracts and control 
antibiotics as above, were spot inoculated 
(2×106 cfu per spot for bacteria and 2×105 
spores per spot for fungi). The inoculated 
plates were then incubated at 37 °C for 24 
hrs (bacteria) and 30 °C for 96 hrs (fungi). 
For broth dilution tests, 0.1 ml of 
standardized suspension of bacteria (106 
cfu/ml) or fungal spores (5×105 spores/ml) 
were added to each tube (containing crude 
extracts at a final concentration of 0–5000 
µg/ml for bacteria and 0–64 mg/ml for fungi) 
and incubated at 37 °C for bacteria and at 
30 °C for fungi for 24 hrs or 96 hrs 
respectively. The lowest concentration of the 
tube or plate which did not show any visible 
growth after macroscopic evaluation was 
considered as the MIC. 
 
Determination of minimal bactericidal 
concentration (MBC) 
MBC was determined by broth dilution 
method. Previously prepared drug dilutions 
(0–3000 µg/ml) of the crude drug (methanol 
extract) were added in Mueller Hinton broth. 
The mixtures were then incubated at 37 °C 
for 18 hrs with shaking on a platform shaker 
at 200 rpm. The concentrations were added 
to the mid-logarithmic phase of growth of 
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the organism and aliquots of 1.0 ml were 
withdrawn at 2 hrs intervals for the 
determination of OD540 and colony count 
(Chattopadhyay et al., 1998a). The lowest 
concentration of crude drug(methanol 
extract) of the tube which did not show any 
visible growth after colony count was 
considered as the MBC (Chattopadhyay and 
Maiti, 2001). 
 
Statistical analysis 
The results for each assay were 
expressed as the mean ± standard deviation 
of three individual experiments. Differences 
in the mean values amongst the treatment 
groups were analyzed by analysis of 
variance (ANOVA). Statistical analyses were 
performed using the software INSTATE. P ≤ 
0.05 was considered to be statistically 
significant. 
3. Results 
Phytochemical investigation of pet ether, 
chloroform, methanol and aqueous extracts of 
the plant Cassia tora revealed differences in their 
phytoconstituents. Extracts of the same drug 
obtained using different solvents also exhibited 
differences in their constituents. Phytochemical 
compounds such as alkaloids, carbohydrates, 
flavonoids, phytosterol and saponins were 
detected in Cassia tora L (Table 2). Solubility of 
each constituent in an herb is very specific to 
different solvents used in the extraction process. 
Hence, chemical nature as well as the 
pharmacological activity of herbal extracts 
obtained using same herb with different 
solvents will be different (Kirtikar and Basu, 
1999).
Table 2. Results of different phytochemical tests 
Extracts Alkaloid Carbohydrate Glycoside Saponin Phytosterol Resin Tannin  Flavonoid 
1) Pet. ether 
extracts 
 
2)chloroform 
extracts 
 
3)Methanol 
extracts 
 
4)Aqueous 
Extracts 
– 
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+ 
 
 
– 
– 
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* „–‟ shows absent of phytochemical 
 *„+‟ shows present of phytochemical 
 
The antimicrobial activity tests of 
methanolic extracts, as shown in Table- 3, 
revealed that the growth of 30 strains of 
Escherichia coli, 2 strains of K. pneumonia, 5 
strains of S. typhi, 8 strains of Vibrio cholera,6 
strains of Bacillus subtilis, 4 strains of 
Pseudomonas aerugenosa , 2 strains of Klebsiella 
sp., 27 strains of Shigella dysenteriae and 30 
strains of Staphylococcus aureus, as well as 3 
species of dermatophytes were affected by 
the extract, as the MIC was <5000 µg/ml (for 
bacteria) and <64 mg/ml (for fungi). 
However, each strain of Shigella dysenteriae 
and Escherichia coli had the MIC of 500 and 
750 µg/ml respectively against the methanol 
extract. In case of aqueous extract, as shown 
in Table-3, 15 strains of Shigella dysenteriae, 13 
strains of Escherichia coli, 2 of Vibrio cholerae, 6 
strains of Bacillus subtilis and 4 strains of 
Staphylococcus aureus show the MIC in <5000 
µg/ml. On the other hand chloroform extract 
of leaves of Cassia tora L demonstrates 15 
strains of Shigella dysenteriae, 4 strains of 
Staphylococcus aureus, 8 of Vibrio cholerae, 4 of 
Pseudomonas aeruginosa, 6 strains of Bacillus 
subtilis and 13 strains of Escherichia coli show 
the MIC in <5000 µg/ml (Table-3). Petroleum 
ether extract had no such antimicrobial 
activity. These results indicate that the 
different extracts of the herbs under study 
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exhibit antibacterial activity and among the 
various extracts, methanolic extracts have 
shown better activity as compared to other 
extracts with respect to similar bacteria. This 
indicates that methanolic extracts are better 
as compared to other extracts. 
 
 
Table-3. Antimicrobial activities of different leaves extracts of Cassia tora L. 
 
Name of bacteria 
No of 
strains 
tested 
Minimum inhibitory concentrations (µg/ml) 
Chloroform 
extracts 
Methanol 
extracts 
Aqueous 
extracts 
Amoxicillin Gentamicin 
Staphylococcus aureus 4 3000 1000 5000 0.5 1 
Staphylococcus aureus 13 >5000 3000 >5000 0.5 2 
Staphylococcus aureus 7 >5000 4000 >5000 1 16 
Staphylococcus aureus 6 >5000 5000 >5000 4 1 
Bacillus subtilis 6 4000 3000 4000 1 1 
Pseudomonas aerugenosa 4 4000 4000 >5000 8 64 
Escherichia coli 1 3000 750 4000 64 1 
Escherichia coli  12 5000 2000 5000 128 2 
Escherichia coli 17 >5000 4000 >5000 128 1 
Vibrio cholerae  2 4000 3000 4000 256 1 
Vibrio cholerae  6 5000 4000 >5000 >256 1 
Salmonella typhi 5 >5000 5000 5000 >256 1 
Klebsiella pneumoniae  2 >5000 5000 >5000 256 4 
Klebsiella.pneumoniae  3 >5000 >5000 >5000 256 4 
Proteus vulgaris 5 >5000 >5000 >5000 >256 64 
Shigella dysenteriae 1 2000 500 2000 >256 1 
Shigella dysenteriae 14 3000 2000 3000 >256 8 
Shigella dysenteriae  12 >5000 4000 >5000 >256 16 
 
 
Name of Fungi 
No of 
strains 
tested 
Minimum inhibitory concentrations (mg/ml) 
Chloroform 
extracts 
Methanol 
extracts 
Aqueous 
extracts 
Nystatin 
Candida albicans 1 64 16 32 1 
Candida lichinoformis 1 >64 32 >64 4 
Cryptococcus neoformans 1 >64 32 64 0.5 
Trichophyton mentagrophytes 1 >64 >64 >64 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. Different bacterial strains exhibit different zone diameter (in mm) in their MIC value of different 
extracts of C. tora L. leaves with respect to gentamicin disk (values are mean ± SEM; n = 4) 
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Different bacterial stains exhibit different 
zone diameter (in mm) in their MIC value of 
chloroform extract, methanolic extract and 
aqueous extract of C. tora L. with respect to 
gentamicin disk in Fig. 1 chloroform, 
methanolic and aqueous extract exhibit 
highest zone of inhibition were 14.5 mm, 16 
mm and 13 mm against the strain of Shigella 
dysenteriae 1, Shigella dysenteriae 1 and Shigella 
dysenteriae 8 respectively. In the other hand, 
methanolic extracts showed highest zone 
diameter (10.2mm) against Candida albicans 
(Fig.2).
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. Different extract of C. tora L. exhibit different zone of inhibition in different fungal strains with respect 
to Nystatin in MIC value (values are mean ± SEM; n = 4). 
 
MBC was always found to be 3 to 4-fold 
higher than MIC values. The results also 
revealed that the extract exhibited 
bacteriostatic activity at lower concentrations 
but bactericidal at higher concentrations. The 
inhibitory effect of the extract of C. tora L. was 
on susceptible bacterial species (Escherichia 
coli ATCC 25938 and Shigella dysenteriae 1) at 
different concentrations showed that the 
growth of these organisms were decreased by 
increasing concentration of the extract and 
were inhibited at their MBC values which 
were 2500µg/ml and 2000µg/ml of 
Escherichia coli ATCC 25938 and Shigella 
dysenteriae 1 respectively. The inhibitory effect 
of the extract was also demonstrated by the 
time dependent in vitro growth (Fig. 3).
 
 
 
 
 
 
 
 
 
 
Fig. 3. Log CFU/ml against different concentration of methanolic extracts of Cassia tora L. 
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Fig. 4. Time dependent in vitro growth curve of S. dysenteriae 1 and Escherichia coli ATCC25938 at their MIC 
values against methanolic extract of C. tora L. leaves 
 
 
4. Discussion
Our preliminary investigation showed 
that all chloroform, methanol and aqueous 
extracts of ethno medicinal plant Cassia tora L. 
(leaves) were active against human 
pathogens (120 bacterial strains and 4 fungal 
strains) used in this study. Phytoconstituents 
present in plants namely flavonoids, 
alkaloids, tannins and triterpenoids are 
producing exciting opportunity for the 
expansion of modern chemotherapies against 
wide range of microorganisms (Dewenjee 
et.al., 2007)s 
Literature also reveals that, S. aureus and 
S. dysenteriae being the most susceptible 
organism, this drug could be more effective 
in infections related to S. aureus and S. 
dysenteriae rather than other bacterial 
infections (Patel and Patel, 1957; Awal et al., 
2004).  
The MIC value of the active plant 
extracts obtained in this study were lower 
than the MBC values suggesting that the 
plant extracts were bacteriostatic at lower 
concentration but bactericidal at higher 
concentration.  
Traditionally Cassia tora L. is used 
externally to treat fungal infections in 
Malaysia, (Abdul Rahim 1996). The results 
from this current study showed that 
methanolic extract of Cassia tora L. had 
antifungal properties on Candida albicans, 
Candida lichinoformis and Cryptococcus 
neoformans. Graybill (1988) reported that 
many commercial antifungal drugs induce 
adverse drug reactions/toxicities that 
include liver, kidney and gastrointestinal 
toxicities. Increase of hepatic enzymes up to 
7% in patients that received continuous 
antifungal drug therapy (Restrepo et al. 1986). 
Herbal remedies often do not induce adverse 
effects (Perry, 1980). Alternative medicine 
has become a popular remedy to various 
types of aliments. 
All these findings indicate that Cassia tora 
L extracts possess antibacterial activity and 
they cause lysis and eradicate bacteria by 
degrading bacterial cell walls. By the 
findings and purification of the active agent 
that is present in the extract of C. tora L., it 
will be possible to discover new natural 
drugs serving as chemotherapeutic agents 
for treatment with nosocomial pathogens. 
Other different studies are required to 
understand the mechanism of this herbal 
extracts (which is cheaper, easily available 
and safe in comparison to other synthetic 
antimicrobial drugs) for the treatment of 
various infections, skin diseases and 
intestinal disorders.  
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